Termination of Registration of a Class of Security Under Section 12(b) (15-12b)
August 10 2017 - 4:07PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number:
001-36828
Nexvet Biopharma
public
limited company
(Exact name of registrant as specified in its charter)
Unit 5, Sragh Technology Park
Rahan Road, Tullamore
Co. Offaly, R35 FR98, Ireland
+353 5793 24522
(Address,
including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Ordinary shares,
nominal value $0.125 per share
(Title of each class of securities covered by this Form)
None
(Titles of all
other classes of securities for which a duty to file reports under Section 13(a) or 15(d) remains)
Please place an X in the
box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
|
|
|
|
Rule 12g-4(a)(1)
|
|
☒
|
|
Rule 12g-4(a)(2)
|
|
☐
|
|
Rule 12h-3(b)(1)(i)
|
|
☒
|
|
Rule 12h-3(b)(1)(ii)
|
|
☐
|
|
Rule 15d-6
|
|
☐
|
|
Rule 15d-22(b)
|
|
☐
|
Approximate number of holders of record as of the certification or notice date: 1
Pursuant to the requirements of the Securities Exchange Act of 1934, Nexvet Biopharma public limited company, has caused this
certification/notice to be signed on its behalf by the undersigned duly authorized person.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nexvet Biopharma public limited company
|
|
DATE: August 10, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Damian Lismore
|
|
|
|
|
|
Name:
|
|
Damian Lismore
|
|
|
|
|
|
Title:
|
|
Authorized officer
|
Instruction: This form is required by Rules
12g-4,
12h-3
and
15d-6
of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of
Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized person. The name and title of the person signing the form shall be typed or printed under the
signature.
NEXVET BIOPHARMA PLC (NASDAQ:NVET)
Historical Stock Chart
From Apr 2024 to May 2024
NEXVET BIOPHARMA PLC (NASDAQ:NVET)
Historical Stock Chart
From May 2023 to May 2024
